Home > Research > National Blood Foundation > NBF Hall of Fame NBF Hall of Fame Page Content NBF introduced its Hall of Fame in 2007 recognizing a prestigious and select group of NBF grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine, cellular therapies, or patient blood management and who demonstrated exemplary leadership within the field. This important recognition was reinstated annually in 2015 inducting one to three new members each year that meet the following criteria: Eligibility Criteria Must be an NBF Scholar: completed NBF funded research. Must have served on three or more AABB committees or workgroups. (AABB Board of Directors, NBF/NBFRET Board of Trustees and TRANSFUSION Editorial Board included.) Demonstrates a successful career and exemplary leadership through commitment, forward thinking, and various contributions to the field. Must be a current AABB Individual Member. 2017 Members Jose Cancelas, MD, PhD Professor of Pediatrics University of Cincinnati College of Medicine Deputy Director, Hoxworth Blood Center Leader, Stem Cell group of the Cancer & Blood Diseases Institute of Cincinnati Children's Hospital Medical Center “The National Blood Foundation was a crucial step in my career since it provided me with the first source of extramural funding to support my research project in 2005. As a result, I was able to generate data that cemented the fundamentals of my research endeavors.” More NBF Grant Year: 2005 NBF Research Project Title: “Mobilization of Hematopoietic Stem Cells by Reversible Inhibition of Rac-Type Rho GTPases: Demonstration of Proof-of-Concept for Future Clinical Applications.” Jose Cancelas, MD, PhD is Professor of Pediatrics at the University of Cincinnati College of Medicine and Deputy Director of Hoxworth Blood Center. He is also leader of the Stem Cell group of the Cancer & Blood Diseases Institute of Cincinnati Children's Hospital Medical Center and holds the Beatrice C. Lampkin Endowment for Stem Cell and Hematotherapy Research. He has published over 140 peer-reviewed manuscripts in the areas of hematopoiesis and transfusion/cell therapies. His laboratory is funded by the NIH, US DoD and different private foundations and corporations. His basic biology laboratory has contributed to the elucidation of the cellular and molecular mechanisms of hematopoietic stem cell and granulocyte progenitor activity in health and leukemia and provided the basis for understanding the physiological cell-autonomous and microenvironment/cytokine dependent mechanisms that control hematopoietic stem cell-activity in the bone-marrow microenvironment. His translational work is focused on the development of new blood and cell therapy products with augmented efficacy and/or safety profiles in the areas of transfusion, stem cell transplantation and immunotherapy. His clinical group has optimized methods of progenitor and granulocyte collection for transfusion in neutropenic patients and validated novel methods to preserve and store T lymphocytes, red cells and platelets. Laura Cooling, MD, MS Professor, Department of Pathology University of Michigan Associate Medical Director of Transfusion Medicine Medical Director for the Cellular Therapy and Immunohematology Reference Laboratories “The NBF was an important step in my early career as a young faculty member transitioning into academic medicine. It provided a foundation for subsequent clinical and translation studies during my career in the areas of immunohematology and bone marrow transplantation support.” More NBF Grant Year: 2003 NBF Research Project Title: ““Molecular Analysis of Globo- and Lacto-Family Glycosyltransferases: Molecular Etiology of the LKE-Negative and LKE-Weak Phenotypes.” Laura Cooling, MD, MS is a Professor in the Department of Pathology at the University of Michigan. She is an Associate Medical Director of Transfusion Medicine and serves as the Medical Director for the Cellular Therapy and Immunohematology Reference Laboratories. She has served on multiple AABB committees including the Education Committee (Chair), Annual Meeting Education Program Unit (Chair), Continuing Education Advisory Committee, Abstract Selection Committee, Strategic Abstract Working Group (Chair), National Blood Foundation grant review, Transfusion Medicine Scientific Section Coordinating Committee, and Standards Committee. She has also participated in several AABB publications including the Technical Manual and Blood Transfusion Therapy Physician’s Handbook. In addition to AABB, she is active in ASFA educational and research activities and was recently awarded the 2016 ASFA Lecturer award. She has authored or co-authored nearly 200 articles, book chapters and abstracts in the field of transfusion medicine, particularly in the areas of immunohematology and stem cell collection. Recent and ongoing studies include completion of the platelet glycolipidome, including inherent donor-specific variation; a large comprehensive review of Blood Groups in Host Susceptibility and Infection for the American Society of Microbiology; pre-clinical studies in therapeutic management of CAIHA; and several papers in pediatric and adult stem cell transplantation. James D. Gorham, MD, PhD Medical Director, Transfusion Medicine Services Chief, Division of Laboratory Medicine, and Professor, Department of Pathology University of Virginia “NBF was the very first grant for my nascent research lab as an independent Principal Investigator, and was instrumental in launching our early research efforts focusing on cytokines in transfusion biology, tolerance, and autoimmunity. The NBF holds a special place in my heart.” More NBF Grant Year: 2000 NBF Research Project Title: “T Cell Cytokine Secretion in a Murine Model of Transfusion-associated ImmunoModulation (TRIM).” Jim Gorham received the MD PhD degrees from NYU in 1992, and completed residency training in Laboratory Medicine as well as post-doctoral research experience in Immunology at Washington University. He joined Dartmouth Medical School as Assistant Professor in 1998, and began his independent research lab focusing on the role of cytokines in modulating immune responses, garnering the NBF grant as his first extramural funding. While at Dartmouth, Dr. Gorham completed a Fellowship in Transfusion Medicine. He also founded a highly successful shared resource facility (DartMouse) with a national reputation, and directed Dartmouth’s MD-PhD training program. He was recruited to UVA in 2015, where he serves as Chief of the Division of Laboratory Medicine, and Medical Director of Transfusion Medicine Services. Dr. Gorham has made research contributions in a variety of fields, including not only Transfusion Medicine, but also Immunology, Hepatology, and Genetics. Recently, he has turned his attention to implementing best practices in Transfusion Medicine and in Laboratory Medicine. Dr. Gorham has published over 50 peer-reviewed papers, has held several NIH and non-NIH grants, is on the Editorial boards of Laboratory Investigation and the Journal of Immunology, has served on multiple NIH study sections, and has been a consistently loyal grant reviewer for the NBF since 2003. He is a contributor to the AABB Technical Manual, and is a regular manuscript reviewer for Transfusion and other journals in the field. 2016 Members Jeanne E. Hendrickson, MD Associate Professor of Laboratory Medicine and Pediatrics Associate Medical Director of the Transfusion Medicine Service Yale University “Early career funding by the National Blood Foundation was instrumental in allowing Dr. Hendrickson the time and resources to develop her red blood alloimmunization research ideas. The NBF grant that Dr. Hendrickson was awarded also provided her with confidence that her research ideas were worthy of exploration.” More NBF Grant Year: 2006 NBF Research Project Title: “Effect of Host Inflammation On Alloimmunization to RBC Transfusion.” Jeanne Hendrickson, MD, is an Associate Professor of Laboratory Medicine and Pediatrics at Yale University, and the Associate Medical Director of the Transfusion Service. Trained in Pediatric Hematology/Oncology and Transfusion Medicine, Dr. Hendrickson’s clinical interests include optimizing transfusion support for children. Her translational research interests revolve around understanding factors that influence red blood cell alloimmunization in transfusion and pregnancy settings. Her long term goals include developing strategies to prevent the formation of RBC alloantibodies in patients at highest risk of this complication, as well as developing therapies to mitigate the dangers of existing RBC alloantibodies. Steven L. Spitalnik, MD Vice-Chair of Laboratory Medicine and Professor Department of Pathology & Cell Biology Columbia University “I received an NBF grant soon after arriving at Columbia University. I had decided to take the risky step of radically changing my research focus to use mouse models to study poorly understood issues in transfusion medicine, such as the mechanisms underlying hemolytic transfusion reactions. This funding was critically important in allowing us to change our focus and succeed in a new area.” More NBF Grant Year: 2003 NBF Research Project Title: “Hemolytic Transfusion Reactions: A Transgenic Mouse Model.” Before arriving at Columbia University in 2003, Dr. Spitalnik was a faculty member at the University of Pennsylvania (1985-1998) and the University of Rochester (1998-2003). He received his M.D. from the University of Chicago, pursued residency training in anatomic and clinical pathology at the University of Rochester, and research training in molecular biology and glycobiology at the University of Rochester and the National Institutes of Health, respectively. Dr. Spitalnik has held committee and leadership positions in various organizations, including the AABB, the Academy of Clinical Laboratory Physicians and Scientists, and the American Society of Hematology. He has published over 180 papers and is on the editorial boards of Transfusion, Transfusion Medicine Reviews, and Current Opinion in Hematology. In addition, he has served as a member and chair of multiple study sections for the National Institutes of Health. Dr. Spitalnik’s initial research in glycobiology often used human blood group antigens as models. Over the last 10 years, he has studied the consequences of red blood cell clearance following transfusion, during hemolytic transfusion reactions, in G6PD-deficiency, and in malaria. He is currently supported by grants from the National Institutes of Health. Karina Yazdanbakhsh, PhD Executive Director of Research Lindsley F. Kimball Research Institute (LFKRI) New York Blood Center “The NBF grant support allowed me to pursue a new exciting research direction in transfusion medicine and to secure my first R01 and American Heart Association grants. I am forever grateful to the NBF for providing me with the crucial support to jumpstart my career in transfusion medicine.” More NBF Grant Year: 2000 NBF Research Project Title: “Recombinant Antigens as Tools for Identification of Alloantibodies in Patients' Sera.” Karina Yazdanbakhsh, PhD is the Head of Laboratory and Member of the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center. The focus of her research is characterization of cellular immune responses against blood components in the context of alloimmunity and autoimmunity. Supported by funding from NIH/NHLBI, she has been investigating the immunoregulatory networks that control development of antibodies (alloimmunization) against transfused red cells in patients with sickle cell anemia. By better understanding these processes, the goal is to not only identify immune biomarkers of alloimmunization to predict antibody responders but also to develop targeted therapies to prevent alloimmunization in this patient population. She also studies cellular and molecular aspects of platelet autoimmunity in patients with immune thrombocytopenia (ITP) with the goal of developing new and improved treatments. Current research focus funded by NIH/NHLBI is on identifying immunological signatures of ITP drug response. 2015 Members Larry J. Dumont, MBA, PhD Associate Director and Senior Investigator Blood Systems Research Institute Denver, Colorado “The NBF funding was central to completion of my PhD, and has been a key in transitioning to an academic focus that provides a strong bridge between product development, academic research, education and delivery of clinical care. This has strengthened my contributions to the safe and efficacious care of patients.” More NBF Grant Year: 2002 NBF Research Project Title: “Human Cytomegalovirus (HCMV) Reactivation – Human Exposure Model and Mechanism D.” Dr. Dumont received an MBA from the University of Phoenix and a PhD in clinical sciences from the University of Colorado Health Sciences Center in Denver. As Associate Director at Blood Systems Research Institute (BSRI) in Denver, he is establishing and expanding BSRI. Dr. Dumont spent 27 years at GAMBRO BCT in various technical capacities where he developed and lead the PASSPORT study. He has been actively involved with the Biomedical Excellence for Safer Transfusion Collaborative (BEST) for 23 years, and is the immediate past Chair of BEST. Dr. Dumont has been an invited speaker at meetings of the FDA Blood Product Advisory Committee, the US Department of Health and Human Services Advisory Committee on Blood Safety and Availability, the Paul-Ehrlich-Institute, and various national and international congresses. He is currently an Associate Editor of Transfusion. His current interests are in platelet and red blood cell physiology, cryopreservation of platelets, the red blood cell storage lesion, in vivo cell survival kinetics, and clinical outcomes in transfusion medicine. Jill R. Storry, PhD Associate Professor Division Hematology & Transfusion Medicine Department of Laboratory Medicine Lund University Technical Director Immunohematology Clinical Immunology and Transfusion Medicine Office of Medical Services “My NBF grant permitted me to establish myself in a new country and gave stability to my post-doctoral employment. Those early results led to further funding from other local sources, and to the discovery of a novel erythrocyte protein. NBF grants are an enormously important source of research funding in Transfusion Medicine and Cellular Therapy.” More NBF Grant Year: 2006 NBF Research Project Title: “Characterization of the Vel Blood Group System.” Dr. Jill Storry is responsible for the Immunohematology laboratories within the Department of Clinical Immunology and Transfusion Medicine, Lund. Dr. Storry is an AABB National Blood Foundation Scholar for her recent discovery of the Vel blood group system. This blood group system is one of many that she is interested in, both at the level of antigen polymorphism but also in the role of polymorphism in pathogen-erythrocyte interaction and these areas form the focus of her continued research. Awards include the BBTS Margaret Kenwright and Race & Sanger Awards, as well as the AABB Sally Frank Award. She has authored over 60 original papers, reviews and text books, and given over 100 talks at international and national conferences and courses. She is member of the Editorial Boards of Transfusion Medicine Reviews, Transfusion and Immunohematology, and a peer reviewer for these and other scientific journals; the Chair of the ISBT Working Party on Red Cell Immunogenetics and Red Cell Nomenclature and a member of the ISBT Working Party on Rare Donors. James C. Zimring, MD, PhD Director of Transfusion Medicine Research Bloodworks Northwest Professor Departments of Laboratory Medicine and Hematology University of Washington “My NBF award came at a crucial time, early in my career, when it was unclear in what direction my lab would develop. The support was indispensable in allowing me to develop a mature research program, focused on transfusion biology, which has been the basis of my research career.” More NBF Grant Year: 2004 NBF Research Project Title: “Selective Induction of Allotolerance in Bone Marrow Transplantation.” James Zimring obtained a B.S. in chemistry, a Ph.D. in Immunology, and an M.D., all from Emory University; he is board certified in Clinical Pathology. Dr. Zimring was an Assistant and then tenured Associate Professor at Emory where he built a basic science program focusing on immunology of transfused RBCs and Platelets. In 2012, Dr. Zimring joined the BloodworksNW Research Institute in Seattle. He currently runs an NIH funded laboratory, is author on over 90 papers, is an active participant in NIH grant review and is on the editorial board of the journals Transfusion and Transfusion Medicine Review. Dr. Zimring has received the David B. Pall award (now the Jack Latham Memorial Award for Innovative Research) from AABB, the Jean Julliard award from ISBT, and the Ellis Benson award from ACLPS. He received the Herbert Perkins Scientific Lectureship and Award, and delivered the Claes F. Högman Lectureship. He is also an elected member the American Society for Clinical Investigation. Dr. Zimring is a dedicated teacher and in 2011 received the Crystal Apple Award from Emory University for “Excellence in Graduate Education and Instruction”. 2007 Inaugural Members James P. AuBuchon, MD, FCAP, FRCP(Edin) President and Chief Executive Officer Bloodworks Northwest Professor of Medicine (Hematology) and of Laboratory Medicine University of Washington Seattle, Washington AABB Past President “The support I received from NBF was critical in allowing me to start my career in radiolabeling and component improvement.” More NBF Grant Year: 1985 NBF Research Project Title: “Use of Indium111 as a Red Cell Label in Survival Studies.” A graduate of the University of Michigan, Dr. AuBuchon trained at the National Institutes of Health before serving in blood center and national headquarters positions of the American Red Cross Blood Services. Before joining Bloodworks in Seattle, he spent 18 years at Dartmouth-Hitchcock Medical Center as the Medical Director of the Blood Bank and Transfusion Service and then as the E. Elizabeth French Professor and Chair of Pathology and Professor of Medicine. His research has paralleled a long-standing interest in improving component collection and storage, documenting their effectiveness through radiolabeling. He also has been active in developing processes to improve recipient safety through identification of the benefits and costs of new safety initiatives. Dr. AuBuchon served as a member of the Advisory Committee on Blood Safety and Availability and has chaired the BEST Collaborative. He was elected a Fellow of the Royal College of Physicians of Edinburgh and is a Past President of the AABB. Michael P. Busch, MD, PhD Director Blood Systems Research Institute Senior Vice President Blood Systems Professor of Laboratory Medicine UCSF “Although an investigator on grants prior to my NBF-grant in 1992, this was my first PI-status grant. The NBF grant led to a publication in Blood and development of the Viral Activation in Transfusion Study. Over the subsequent decades I have led dozens of similar studies with BSRI as the Central Laboratory.” More NBF Grant Year: 1992 NBF Research Project Title: “Impact of Homologous Blood Transfusion on HIV Replication and Disease in Vivo.” Dr. Michael Busch earned his MD and PhD degrees at USC followed by residency training in Pathology, Laboratory Medicine and Transfusion Medicine at UCSF. He is the founding Director of Blood Systems Research Institute (BSRI) in San Francisco and Senior Vice President for Research and Scientific Affairs at Blood Systems, a national network of blood centers and donor testing laboratories. Dr. Busch’s major research interests include: 1) epidemiology, pathogenesis and laboratory diagnosis and monitoring of transfusion-transmitted viral infections, including HIV-1/2, HTLV-I/II, HBV and HCV, as well as blood safety implications of new and emerging infectious diseases (e.g., WNV, Dengue viruses, chikungunya virus, T. cruzi, babesia); 2) development and implementation of improved blood donor screening assays/algorithms, with particular focus on nucleic acid amplification technologies and pathogen reduction technologies; 3) mechanisms and prevention of immunological consequences of transfusions, including microchimerism, graft-vs-host disease, transfusion-related acute lung injury and alloimmunization; and 4) mechanisms of HIV latency and development of novel assays to quantify HIV reservoirs in ART-suppressed subjects in the context of cure research interventions. Dr. Busch has published ~450 peer-reviewed original scientific articles and over 150 review articles, editorials and book chapters. Sunny Dzik, MD Co-Director Blood Transfusion Service Massachusetts General Hospital “Participation in the NBF-- as an applicant, an awardee, a reviewer of grant applications, and as a financial contributor—has built strong and positive relationships during my career in academic Transfusion Medicine. I look at recent and current NBF awardees and I am extremely proud of their scientific achievements and their investigative enthusiasm. NBF is one of the best parts of our Profession. Congratulations and many thanks to those who make the NBF stronger each year.” More NBF Grant Year: 1994 NBF Research Project Title: “Transient Microchimerism Following Allogeneic Blood Transfusion.” Dr. Dzik’s clinical interests are in transfusion medicine, hemostasis, and non-cancer hematology. He is a founding member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. In 2002, Dr. Dzik led a large, international, multicenter BEST Study focused on blood grouping errors due to miscollected samples. A previous international study with this group focused on standardization of CD34+ cell counting during progenitor cell collections. Dr. Dzik's research interests include management of the coagulopathy of liver disease, clinical use of blood components, biologic consequences of recipient exposure to allogeneic donor leukocytes, and patient safety in transfusion. Studies are currently underway on oxygen delivery to children with profound anemia due to malaria. Dr. Dzik is devoted to mentoring the next generation of leaders in academic Transfusion Medicine. In recent years, he has had the great honor to advise on research projects undertaken by recent NBF awardees, ranging from the importance of ABO blood groups in the pathophysiology of severe malaria to the role of protein C in purpura fulminans. Most recently, working with former NBF awardees and colleagues he has done fundamental clinical research on the delivery of oxygen to tissues by Red Blood Cells after transfusion. Christopher D. Hillyer, MD President and CEO New York Blood Center Professor, Department of Medicine Weill Cornell Medical College New York, New York AABB Past President “The value of the NBF grant to me was substantial. It was seed funding at a point in my career when I would not have been able to get major, investigator initiated grants. It was peer reviewed at a very good and high level, allowing me to learn the process. These set the stage for me to get R01 and even P01- level funding. Through the NBF grant process, I was also able to meet other investigators and network in a way that supported my career development.” More NBF Grant Year: 1991 NBF Research Project Title: “Peripheral Blood Stem Cells for Allogeneic Transplantation: Development of an Animal Model-Initial Phase Investigations.” Christopher D. Hillyer, MD, is President and CEO of New York Blood Center and Professor, Department of Medicine, Weill Cornell Medical College, NY, NY. Previously, he was the tenured, endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine and served as director of the Emory Center for Transfusion and Cellular Therapies with responsibility for all aspects of clinical and academic transfusion medicine at Emory's seven principal hospitals. Dr. Hillyer is an editor of eleven textbooks in transfusion medicine including the 16-18th editions of the AABB Technical Manual, author of over 150 articles pertaining to transfusion, HIV, and herpes viruses, most notably cytomegalovirus. Nationally recognized as an expert in hematology and blood transfusion, Dr. Hillyer is also a past-president, board of directors of AABB and a former trustee of the National Blood Foundation. Dr. Hillyer has been awarded many millions of dollars in research funding from the National Institutes of Health, the Centers for Disease Control and Prevention and other agencies. He is an associate editor of Transfusion and serves on several other editorial boards. Dr. Hillyer is board certified in transfusion medicine, hematology, medical oncology and internal medicine. He received his BS from Trinity College, and his MD from the University of Rochester School of Medicine, with postgraduate training and fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center. Paul D. Mintz, MD Senior Vice President and Chief Medical Officer Verax Biomedical Inc. AABB Past President “The National Blood Foundation Grant I received played a key role in the transfusion medicine research program at the University of Virginia and in my career development. This award allowed us to study the relationship of platelet morphology to platelet recovery and survival and to learn the techniques required to radiolabel platelets and to perform these studies. We subsequently applied this knowledge to other research.” More NBF Grant Year: 1986 NBF Research Project Title: “Correlation of Non-invasive Assessment of Platelet Morphology with Platelet Recovery and Survival.” Dr. Mintz currently serves as Senior Vice President and Chief Medical Officer of Verax Biomedical Inc. Prior to this appointment, he was the Director, Division of Hematology Clinical Review in the Office of Blood Research and Review at the Center for Biologics Evaluation and Research, Food and Drug Administration. Before joining the FDA in 2011, Dr. Mintz was a tenured Professor of Pathology and Medicine at the University of Virginia (UVA) Health System serving as Vice Chair of Pathology and Chief of the Division of Clinical Pathology and as Medical Director of the Clinical Laboratories and Transfusion Medicine Services. While at UVA, Dr. Mintz created the fellowship in transfusion medicine that has contributed to the career development of more than 25 early career physicians. Dr. Mintz served on the AABB Board of Directors for nine years including a term as President from 2004-2005 and chaired and served on many AABB Committees. As AABB President, he conceived and assured the development of the now published AABB guidelines for red cell, platelet and plasma transfusions. Dr. Mintz received the AABB’s John Elliott Memorial Award in 2015. Previously, he was also the recipient of a Transfusion Medicine Academic Award from the NHLBI. Dr. Mintz has published more than 100 peer-reviewed papers related to transfusion medicine, is on the editorial board of TRANSFUSION and other journals, and has served as the principal investigator for many clinical and device trials. Joann Moulds, PhD, MT (ASCP)SBB Scientific Director Immunohematology Center Grifols Diagnostic Solutions Inc. “My NBF grant allowed me to obtain the experience with molecular techniques as applied to blood groups that I needed to become a leader in the field of molecular immunohematology and become an advocate for the use of blood group genotyping in patient care.” More NBF Grant Year: 1992 NBF Research Project Title: “Determination and Localization of Human Blood Group Polymorphisms on Complement Receptor One (CR1).” Following post-doctoral work at Washington University School of Medicine, an NBF grant to Dr. Moulds funded her ongoing research on complement receptor type one (CR1), its polymorphisms and relation to disease. Thru these studies she identified the Knops antigens on CR1 and showed that CR1 played a role in the rosetting of. P. falciparum infected cells to uninfected red cells. Clinical data which emerged from her studies in Mali also showed that blood group O red cells had reduced rosetting and this correlated with less severe malaria. The extensive experience with molecular techniques acquired during her research led Joann to a position at LifeShare Blood Centers where she bécame involved in the newly evolving field of blood group genotyping. Accordingly, Dr. Moulds served as chairperson of the AABB program unit that produced the first Standards for Molecular Testing for Red Cells, Platelet and Neutrophil Antigens in 2008. Dr. Moulds left LifeShare in 2014 to become Scientific Director of the new Immunohematology Center at Grifols Diagnostic Solutions where her group continues to investigate the molecular aspects of blood groups and relates them to serology. Sandra J. Nance, MS, MT (ASCP) SBB Senior Director Immunohematology Reference Laboratories American Red Cross “AABB’s National Blood Foundation grant was the first grant I received which led to a subsequent publication which was my 8th first author publication, and the 2nd reporting use of the Monocyte Monolayer Assay. These early research years were formative and laid the foundation for continuing research, presentations and publications and the importance of teaching others. The grant I received from the NBF is a continuing source of pride and the MMA continues to be used to predict transfused RBC survival nearly 30 years later.” More NBF Grant Year: 1989 NBF Research Project Title: “A comparison of the Efficiency of the Monocyte Monolayer Assay IgG Subclassing, OD450 Amniotic Fluid, and Ultrasonography in Prediction of the Severity of Hemolytic Disease of the Newborn.” As Senior Director for Immunohematology Reference Laboratories for the American Red Cross, Ms. Nance provides leadership to the National Reference Laboratory for Blood Group Serology and National Reference Laboratory for Special Testing and process design oversight to 45 Immunohematology Red Cross Reference Laboratories across the United States and is the Senior Director of the American Rare Donor Program. She is an Adjunct Assistant Professor at the University of Pennsylvania, Division of Transfusion Medicine & Therapeutic Pathology Department of Pathology and Laboratory Medicine. She has a master’s degree in Pathology from the University of Maryland and received her SBB from the Johns Hopkins Medical Institutions. Ms. Nance has held leadership positions in the AABB, ASCP, ICII, and ISBT. Among other roles, she was on four nominating committees for AABB and ASCP. She chaired the ISBT Working Party on Rare Donors, conceptualized the new ISBT Working Party on Immunohematology and was the first Chair. She is active in Clinical Rotation Management for NIH and JHMI SBB Students and Fellows at Thomas Jefferson University and University of Pennsylvania. She is Editor in Chief of the Immunohematology Journal of Blood Group Serology and Molecular Genetics and has served on the Editorial Board and as a reviewer for Transfusion and is a reviewer for several other journals. She has authored or co-authored over 40 papers, 100 abstracts and edited 9 books. Marion Elizabeth Reid, FIMBS, PhD, DSc(Hon.) Retired Former Director of Immunohematology and Head Immunochemistry New York Blood Center “The NBF is a very valuable stepping-stone for researchers. It follows the NIH format and gave me experience in grant writing.” More NBF Grant Year: 1993 NBF Research Project Title: “Studies on the Surface Markets of Glycophorin in Molecules in Human Red Blood Cells.” Dr. Reid was trained as a medical technologist in Hematology, Blood Transfusion, and Blood Group Serology at the North East Metropolitan Blood Transfusion Service. She later obtained a MSc in Clinical Science, and a PhD in Biochemistry. She has worked in immunohematology reference laboratories in the UK and USA. Marion acquired an extensive serological, biochemical, and molecular knowledge of blood groups and their application to clinical practice and human genetics. She has published over 400 peer-reviewed articles, reviews and chapters. A book she co-authored, the Blood Group Antigen FactsBook, is a well-used and respected reference in immunohematology laboratories. Marion has served on numerous committees and editorial boards, was a reviewer for several journals, received several grants, and holds a patent. A recognized expert she has received numerous awards, including the Ivor Dunsford Award, the Sally Frank Award; the International Woman in Transfusion Award, the Emily Cooley Award, the James Blundell Award, and an honorary Doctorate in Science from the University of Plymouth. Marion willingly shared her knowledge with others—from peers to children. She is now retired and living in England. She is currently co-authoring a book on the history of blood group and one about blood for children. John D. Roback, MD, PhD ProfessorEmory University School of Medicine “Although I received an NBF grant in 1998, when NIH funding was relatively abundant, the NBF award was absolutely critical for jump-starting my transfusion medicine research career and laying the groundwork for my later investigations. In today’s more challenging NIH funding climate, NBF awards are more important than ever for developing the next generation of transfusion medicine investigators.” More NBF Grant Year: 1998 NBF Research Project Title: “The Role of Leukocytes in Transfusion-Transmitted Cytomegalovirus (TT-CMV) Infection: Development of an Animal Model.” Dr. Roback is a Professor (tenured) in the Department of Pathology and Laboratory Medicine of the Emory University School of Medicine. His administrative appointments include Director of the Center for Transfusion and Cellular Therapies, Medical Director of the Emory University Hospital and Emory University Hospital-Midtown Blood Banks, and Vice-Chair of the Section of Clinical Pathology and Laboratory Medicine, and Medical Director of Emory Medical Laboratories. His research interests include development of novel technologies for blood typing and compatibility testing, and elucidating the biochemical and physiological effects of RBC storage on cell functionality and recipient outcomes. In addition to the critical early funding Dr. Roback received from NBF, his work has also been funded by NIH/NHLBI through 2 P01 Program Project awards (PI), 6 R01 grants (3 as PI), and 7 STTR small business awards (6 as PI). He has published 68 peer-reviewed papers, 20 review articles/editorials, 24 book chapters, and has 8 issued patents. Dr. Roback is a member of the Editorial Boards of Transfusion and Transfusion Medicine Reviews, past-Editor of the AABB Technical Manual, and past-Chair of the AABB Clinical Transfusion Medicine Committee. Christopher C. Silliman, MD, PhD Professor of Pediatrics and Surgery School of Medicine University of Colorado Denver Aurora, CO Senior Independent Investigator Research Department Bonfils Blood Center “The NBF was the first organization to take my data seriously and gave me working capital when no one else would. This has led to consistent extramural funding and a rewarding clinical and research career. I will be forever indebted.” More NBF Grant Year: 1998 NBF Research Project Title: “The Pathophysiology of Transfusion Related Acute Lung Injury (TRALI) in an Animal Model and In Vitro Investigation of Endothelium as an Active Participant.” Dr. Silliman’s basic research interests include inflammation and innate immunity, receptor-mediated signaling in neutrophils and vascular endothelium, lipid biochemistry, and Transfusion Medicine with emphasis on transfusion-related acute lung injury (TRALI) and resuscitation following injury. His clinical interests include the etiology of the acute chest syndrome in children with sickle cell anemia and the role of intermediate altitude on children with sickle cell anemia and its role in coagulation with specific regard to venous thromboembolic formation. Dr. Silliman has published >240 papers in peer-reviewed journals, has >300 presentations at national and international meetings. He has trained >40 physicians in basic science and translational research. Dr. Silliman has been fortunate to have received >20 years of extramural funding. He serves as a reviewer for ~20 journals, is a member of the Editorial board of Blood, sits on the Scientific Committee for Transfusion Medicine for the American Society of Hematology National Meeting, and is the Transfusion Medicine Editor for HemOnc Today. Edward Snyder, MD, FACP Professor Laboratory Medicine Yale University Medical School Director, Transfusion/Apheresis/ Tissue/Cell Processing Services Yale-New Haven Hospital AABB Past President “The NBF provided me with funding to start my research in the field of blood filtration. That seed grant grew into a major research effort that afforded me the opportunity to publish papers, participate in local and national research symposia and be recognized as a useful committee member and advisor to National Organizations and Federal Agencies. That small grant of $5,200 paid large dividends and formed the foundation of my career in Transfusion Medicine.” More NBF Grant Year: 1986 NBF Research Project Title: “Calcium-Dependent Proteolysis of Actin During Storage of Platelet Concentrates.” Edward L. Snyder, MD, FACP, graduated from NY Medical College. He was an Internal Medicine Resident and a Hematology Fellow at Montefiore Hospital in the Bronx, NY. Also at Montefiore, he completed a Fellowship in Transfusion Medicine. Dr. Snyder is currently Professor of Laboratory Medicine at Yale University Medical School and Director of the Blood Bank/Apheresis Service at Yale-New Haven Hospital. He is also Chairman of the Yale University Conflict of Interest Committee, and Vice-Chair of the Yale Cancer Center Data Safety Monitoring Board. Dr. Snyder is ABIM board certified in Internal Medicine and Hematology and ABP certified in Transfusion Medicine. He was President of the AABB from 1997-1998 and Chairman of the NMDP BOD from 2009-2010. Dr. Snyder has served on numerous governmental FDA and NIH advisory panels, most recently on an NHLBI R34 Review Group. He is currently a sitting member of the NIH K23 MPOR Study Section. Dr. Snyder is an Associate Editor for Transfusion, and has over 220 publications in the field of Transfusion Medicine. He is a Co-Editor of several books in the field of Transfusion Medicine and Cell Therapy. His active areas of research/clinical interest include Pathogen Reduction, stem cell mobilization and Apheresis Clinical trials. Connie M. Westhoff, SBB, PhD Executive Scientific Director of Immunohematology and Genomics New York Blood Center “The NBF grant brought my research career back to my first love – the field of transfusion medicine -- and the chance to contribute to improve transfusion therapy through genomics.” More NBF Grant Year: 1999 NBF Research Project Title: “Deciphering the Function of the Rh Proteins.” Currently Dr. Westhoff leads the New York Blood Center reference laboratory specializing in complex antibody identification and the use of genomics to find compatible donors for patients with transfusion complications. As an expert in the Rh system, her clinical focus is on improved matching of donors with patients who have SCD and Thalassemia using genomics, funded by an Innovations in Clinical Research Award from the Doris Duke Foundation. Her research focus centers on the production of rare RBCs in culture for reagents, as a first step to production of RBCs for transfusion, funded by NIH. She has published over 80 scientific papers and authored numerous book chapters. She is associate editor for the Immunohematology-Genomics section of Transfusion, an editor of the AABB technical manual, and a reviewer for numerous journals. She has served on many AABB committees including the AABB board of directors, and as chair of the SSCC and the National Blood Foundation grants review committee, as well as the Transfusion Medicine scientific program committee of the American Society of Hematology.